The Diabetes Care Devices (BRIC) Market size is projected to reach USD 4.3 billion by 2025 from USD 1.7 billion in 2020, at a CAGR of 16.2% during the forecast period. Factors such as the increasing diabetic population, the rising awareness of diabetes treatment and management, and favorable national health strategies are expected to drive the growth of the diabetes care devices (BRIC) market.

Key Market Players:
Medtronic plc (Ireland), B. Braun (Germany), DexCom, Inc. (US), Abbott (US), F. Hoffman-La Roche Ltd. (Switzerland), Ascensia Diabetes Care Holdings AS (Switzerland), LifeScan (US), AgaMatrix Holdings LLC (US), Acon Laboratories, Inc. (US), ARKRAY USA, Inc. (US), Novo Nordisk A/S (Denmark), Becton, Dickinson and Company (US), Sanofi (France), Terumo Corporation (Japan), SD Biosensor, Inc. (South Korea), MicroGene Diagnostic Systems Pvt. Ltd. (India), Ypsomed (Switzerland), Dr. Morepen (India), Sinocare, Inc. (China), Bionime Corporation (Taiwan), and Rossmax International Ltd. (Taiwan).

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=375

The diabetes management mobile applications segment is projected to grow at the highest CAGR during the forecast period
Within the type segment, the market is segmented into blood glucose monitoring systems, insulin delivery devices, and diabetes management mobile applications. The diabetes management mobile applications segment is projected to grow at the highest rate during the forecast period, driven by its convenience, simplicity of use, and utility in providing real-time insights regarding diabetic conditions to patients and healthcare professionals for integrated diabetes management.

China held the largest share in the diabetes care devices (BRIC) market.
China held the largest share in the diabetes care devices (BRIC) market in 2019. This dominance is due to the high population of diabetics in the country and increasing government funding for diabetes management and the diabetes care devices industry. India is expected to register the fastest growth during the forecast period, primarily due to opportunities presented by the country, especially in terms of the growing usage of mHealth (mobile health), which supports the diabetes management mobile applications segment.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=375

The research report categorizes the market into the following segments and subsegments:
By Type
• Blood glucose monitoring systems
• Self-monitoring blood glucose monitoring systems
• Continuous glucose monitoring systems
• Test strips/Test papers
• Lancets/Lancing devices
• Insulin delivery devices
• Insulin pumps
• Insulin pens
• Insulin syringes and needles

By End User
• Hospitals & specialty clinics
• Self & home care

Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=375

Related Report:
Point-of-Care-Diagnostic-Market: https://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html